Gestational diabetes & diabetes in pregnancy

Risk of Adverse Pregnancy Outcomes Among Asian Individuals With Gestational Diabetes Mellitus in the U.S., 2016–2021

Diabetes CarePublished Serial cross-sectional study

Authors' conclusion

There was significant heterogeneity in the frequency and risk of APOs among Asian individuals with GDM in the U.S. Disaggregation of the Asian population in diabetes and pregnancy research and surveillance is necessary to identify opportunities for intervention.

Study context

Population
Individuals with GDM and a singleton first livebirth, U.S. birth certificate data 2016–2021
Participants
29,370 / 16,146 / 9,082 / 6,497 / 3,754 / 1,253 / 254,433
Exposure
Asian subgroups vs non-Hispanic White individuals with GDM
  • Indiann = 29,370
  • Chinesen = 16,146
  • Filipinon = 9,082
  • Vietnamesen = 6,497
  • Koreann = 3,754
  • Japanesen = 1,253
  • Whiten = 254,433reference
Outcome
Adverse pregnancy outcomes (APOs)
Methodological detailsU.S. birth certificate data (2016-2021), multivariable analyses
  • U.S. birth certificate data (2016-2021)
  • Multivariable analyses

Main finding

As reported in the abstract

  • All Asian groups had higher likelihood of small-for-gestational-age (SGA) and lower likelihood of large-for-gestational-age (LGA) vs White individuals (multivariable analyses)
  • Findings for other adverse pregnancy outcomes (APOs) were heterogeneous
  • Risk of APOs generally highest among Filipino, then Indian, and lowest among Chinese individuals among Asian groups

Observational data: associations, not effects.

Further findings

Trend in APO frequency 2016–2021

Frequency of hypertensive disorders of pregnancy (HDP), but not other APOs, increased among most Asian groups

Original publication

Risk of Adverse Pregnancy Outcomes Among Asian Individuals With Gestational Diabetes Mellitus in the U.S., 2016–2021. Diabetes Care. Published 10 April 2025. doi:10.2337/dc25-0060

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.